pindolol has been researched along with Precancerous Conditions in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Precancerous Conditions: Pathological conditions that tend eventually to become malignant.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Refsnes, M | 1 |
| Sager, G | 1 |
| Sandnes, D | 1 |
| Sand, TE | 1 |
| Jacobsen, S | 1 |
| Christoffersen, T | 1 |
1 other study available for pindolol and Precancerous Conditions
| Article | Year |
|---|---|
Increased number of beta-adrenoceptors in hepatocytes from rats treated with 2-acetylaminofluorene.
Topics: 2-Acetylaminofluorene; Adenylyl Cyclases; Animals; Cyclic AMP; Dihydroalprenolol; Iodocyanopindolol; | 1986 |